CBChubb LimitedLarge cap · $134.91B · FY ending 2025-12-31
$347.83+0.01% · 2026-07-10 · EOD
57/100 composite
A transparent blend of the four reads below — each opens into the tool it comes from. Not advice.Quality77
margins & F-ScoreValue63
P/E 13.5 · 86% of 12-mo rangeMomentum64
golden · price above 200-daySmart Money23
selling · 1 funds · 0P/3S insidersBullish stackGolden crossAbove 200-day
vs S&P 500+4.0%
6-mo excess Trailing performance1M +7.0%
3M +4.5%
6M +13.4%
YTD +12.2%
1Y +24.2%
P/E vs its last 12 months (our price history): 10.4 low → 14.1 high
Current price sits at the 86th percentile of that window — near the top (richer). We only compare against the price history we own (no paid multi-year multiples — nothing invented).
Piotroski F6/9
fundamental strength ROIC = NOPAT ÷ (debt + equity − cash), using an effective tax rate of 19%. Annual figures from SEC XBRL.
Dividend & capital return
Payout ratio14.6%
comfortable Shareholder yield3.9%
dividends + buybacks Annual figures from SEC cash-flow statements. Shareholder yield = total cash returned ÷ market cap.
Net selling0P / 3S insiders · 1 funds hold · 0 Congress buys
Recent insidersOrtega Juan Luis · Executive Vice President*SELL$1.3M
Keogh John W · President &COOSELL$7.4M
ATIEH MICHAEL G · DirectorSELL$190,468
Fund holders (13F)Davis Selected Advisers (Chris Davis)$389.6M1.8% of book
CongressGilbert CisnerosSELL2026-05-15
Bhealth · 73/100
Self-fundingSelf-funding — profitable · generates cash
No red flags from its filings.
Educational tools — not financial advice. Fundamentals from SEC EDGAR (XBRL); prices are end-of-day (Databento). Scores are a transparent blend of the components shown, computed on our own data — a research aid, not a recommendation.